Onderneming Cellectis S.A. Other OTC
Aandelen
CMVLF
FR0010425595
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutics
100,0
%
| 18 | 100,0 % | 1 | 100,0 % | -96,17% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
France
100,0
%
| 18 | 100,0 % | 1 | 100,0 % | -96,17% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 20-12-99 |
André Choulika
FOU | Founder | 59 | 20-12-99 |
Arthur Stril
DFI | Director of Finance/CFO | 35 | 01-07-18 |
Mark Frattini
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-08-20 |
Stephan Reynier
CMP | Compliance Officer | 55 | 01-04-11 |
Chief Tech/Sci/R&D Officer | 61 | 01-01-01 | |
Human Resources Officer | 54 | 16-11-20 | |
Steve Doares
PRN | Corporate Officer/Principal | - | 21-07-20 |
General Counsel | 42 | 01-01-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 75 | 05-11-20 | |
André Choulika
FOU | Founder | 59 | 20-12-99 |
David Sourdive
FOU | Founder | 57 | 20-12-99 |
Laurent Arthaud
BRD | Director/Board Member | 61 | 28-10-11 |
Pierre Bastid
BRD | Director/Board Member | 69 | 28-10-11 |
Director/Board Member | 57 | 28-06-22 | |
Donald Bergstrom
BRD | Director/Board Member | 52 | 28-06-22 |
Rainer Boehm
BRD | Director/Board Member | 63 | 29-06-17 |
Cécile Chartier
BRD | Director/Board Member | - | 27-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 71 751 201 | 71 751 201 ( 100,00 %) | 0 | 100,00 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
CALYXTPAR 2.28% | 479 264 | 2.28% | 7 447 763 $ |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,05% | 58,71 mld. | |
-2,02% | 41,31 mld. | |
+40,01% | 39,2 mld. | |
-10,22% | 27,4 mld. | |
+13,42% | 26,55 mld. | |
-21,60% | 18,98 mld. | |
+2,89% | 12,51 mld. | |
+22,40% | 11,94 mld. | |
+27,49% | 12,08 mld. |